Description
Ansomone is a kind of sterile, lyophilized formulation of Recombinant Human Growth Hormone (HGH). It used to be 192 amino acid sequence (somatrem) but has since been changed to 191 amino acid (somatropin). Ansomone is derived from engineered E.coli bacteria, which then produce growth hormone identical to the human body’s naturally produced HGH. Ansomone is indicated for growth failure due to endogenous growth hormone deficiency (GHD) and Turner disease or Kidney failure.
Anti-Aging, Body constructing also Fat Loss purposes.
– superior cardiac output
– lowered blood force
– improved immune task
– enlarged human sexual activity
– enchased cholesterol profile
– low organism fat
– improved energy levels
– augmented work performance
– growth stronger bones
– hair re-growth
– younger, tighter, thicker skin
– line removal
– improved power mass
– rejuvenation of major organs which shrink with age.
Pharmacology
Ansomone exerts the same actions of endogenous human growth hormone. It can stimulate proliferation and differentiation of epiphysis chondrocyte, stimulate growth of cartilage matrix cells, stimulate proliferation and differentiation of osteoblast; thus accelerate the linear growth rate and improve epiphysis width. Ansomone® can promote protein synthesis in whole body; reverse the negative nitrogen equilibrium caused by wound and surgery; correct the hypoproteinemia due to severe infection or hepatocirrhosis; stimulate synthesis of immunoglobulin and proliferation of lymphadenoid, macrophage and lymphocyte, thus enhance the ability of infection resistance; stimulate proliferation of collagen oocyte, fibroblast and macrophage in sites of burn and surgery, thus accelerate wound healing; promote synthesis of cardiomyocytes, thus improve cardiac contractility and reduce cardiac oxygen consumption; regulate lipometabolism, thus depress serum cholesterol and low density lipoproteins level; complement insufficiency or deficiency of growth hormone, regulate adults lipometabolism, osteo metabolism, heart and kidney function.
It is reported that the equal pharmacological effect could be achieved via subcutaneous (sc) or intramuscular (IM) administration. Even though SC may lead to a higher concentration of GH in plasma, IM also yields equal in crease of the IGF-l hormone levels.
